View in EDS HTML Full Text PDF Full Text

Utility of In Vitro Bioactivity as a Lower Bound Estimate of In Vivo Adverse Effect Levels and in Risk-Based Prioritization.

Saved in:

Bibliographic Details
Title:	Utility of In Vitro Bioactivity as a Lower Bound Estimate of In Vivo Adverse Effect Levels and in Risk-Based Prioritization.
Authors:	Friedman, Katie Paul¹ (AUTHOR) paul-friedman.katie@epa.gov, Gagne, Matthew² (AUTHOR), Loo, Lit-Hsin³ (AUTHOR), Karamertzanis, Panagiotis⁴ (AUTHOR), Netzeva, Tatiana⁴ (AUTHOR), Sobanski, Tomasz⁴ (AUTHOR), Franzosa, Jill A⁵ (AUTHOR), Richard, Ann M¹ (AUTHOR), Lougee, Ryan R^1,6 (AUTHOR), Gissi, Andrea⁴ (AUTHOR), Lee, Jia-Ying Joey³ (AUTHOR), Angrish, Michelle⁷ (AUTHOR), Dorne, Jean Lou⁸ (AUTHOR), Foster, Stiven⁹ (AUTHOR), Raffaele, Kathleen⁹ (AUTHOR), Bahadori, Tina⁶ (AUTHOR), Gwinn, Maureen R¹ (AUTHOR), Lambert, Jason¹ (AUTHOR), Whelan, Maurice¹⁰ (AUTHOR), Rasenberg, Mike⁴ (AUTHOR)
Source:	Toxicological Sciences. Jan2020, Vol. 173 Issue 1, p202-225. 24p. 2 Diagrams, 5 Charts, 6 Graphs.
Database:	Environment Complete
Full text is not displayed to guests. Login for full access.

Be the first to leave a comment!